SmithKline Beecham launches Epitope's HIV test:
This article was originally published in Clinica
Executive Summary
Following US FDA clearance last month, Epitope's OraSure Western blot confirmatory HIV test is being launched to the healthcare professional market this week (see Clinica No 709, p 17). Marketed by SmithKline Beecham, the test enables both screening and confirmation to be performed on a single oral specimen.